Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapine

Detalhes bibliográficos
Autor(a) principal: Harjivan, Shrika G.
Data de Publicação: 2015
Outros Autores: Pinheiro, Pedro F., Martins, Inês L., Godinho, Ana L., Wanke, Riccardo, Santos, Pedro P., Pereira, Sofia A., Beland, Frederick A., Marques, M. Matilde, Antunes, Alexandra M M
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/152628
Resumo: Funding: This work was supported in part by Fundação para a Ciência e a Tecnologia (FCT), Portugal (PTDC/QUI-QUI/113910/2009, RECI/QEQ-MED/0330/2012, UID/QUI/00100/2013 and IF/ 01091/2013/CP1163/CT0001), and by Interagency Agreement Y1ES1027 between the National Center for Toxicological Research/Food and Drug Administration and the National Institute of Environmental Health Sciences/National Toxicology Program. The opinions expressed in this paper do not necessarily represent those of the U.S. Food and Drug Administration. RW, ALG, ILM and SGH thank FCT for postdoctoral and doctoral fellowships (SFRH/BPD/70953/2010, SFRH/BD/72301/2010, SFRH/BD/75426/2010 and SFRH/BD/ 80690/2011, respectively). AMM also acknowledges Programa Operacional Potencial Humano from FCT and the European Social Fund (IF/01091/2013), and the LRI Innovative Science Award. We thank the Portuguese NMR and MS networks (IST nodes) for providing access to the facilities.
id RCAP_9aee533fbd9416db30686b52e0a9cd56
oai_identifier_str oai:run.unl.pt:10362/152628
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapineActivation pathway to amino acid adductsHealth, Toxicology and MutagenesisToxicologySDG 3 - Good Health and Well-beingFunding: This work was supported in part by Fundação para a Ciência e a Tecnologia (FCT), Portugal (PTDC/QUI-QUI/113910/2009, RECI/QEQ-MED/0330/2012, UID/QUI/00100/2013 and IF/ 01091/2013/CP1163/CT0001), and by Interagency Agreement Y1ES1027 between the National Center for Toxicological Research/Food and Drug Administration and the National Institute of Environmental Health Sciences/National Toxicology Program. The opinions expressed in this paper do not necessarily represent those of the U.S. Food and Drug Administration. RW, ALG, ILM and SGH thank FCT for postdoctoral and doctoral fellowships (SFRH/BPD/70953/2010, SFRH/BD/72301/2010, SFRH/BD/75426/2010 and SFRH/BD/ 80690/2011, respectively). AMM also acknowledges Programa Operacional Potencial Humano from FCT and the European Social Fund (IF/01091/2013), and the LRI Innovative Science Award. We thank the Portuguese NMR and MS networks (IST nodes) for providing access to the facilities.Nevirapine (NVP) is the non-nucleoside HIV-1 reverse transcriptase inhibitor most commonly used in developing countries, both as a component of combined antiretroviral therapy and to prevent mother-to-child transmission of the virus; however, severe hepatotoxicity and serious adverse cutaneous effects raise concerns about its safety. NVP metabolism yields several phenolic derivatives conceivably capable of undergoing further metabolic oxidation to electrophilic quinoid derivatives prone to react with bionucleophiles and initiate toxic responses. We investigated the ability of two phenolic NVP metabolites, 2-hydroxy-NVP and 3-hydroxy-NVP, to undergo oxidation and subsequent reaction with bionucleophiles. Both metabolites yielded the same ring-contraction product upon oxidation with Frémy's salt in aqueous medium. This is consistent with the formation of a 2,3-NVP-quinone intermediate, which upon stabilization by reduction was fully characterized by mass spectrometry and nuclear magnetic resonance spectroscopy. Additionally, we established that the oxidative activation of 2-hydroxy-NVP involved the transient formation of both the quinone and a quinone-imine, whereas 3-hydroxy-NVP was selectively converted into 2,3-NVP-quinone. The oxidations of 2-hydroxy-NVP and 3-hydroxy-NVP in the presence of the model amino acids ethyl valinate (to mimic the highly reactive N-terminal valine of hemoglobin) and N-acetylcysteine were also investigated. Ethyl valinate reacted with both 2,3-NVP-quinone and NVP-quinone-imine, yielding covalent adducts. By contrast, neither 2,3-NVP-quinone nor NVP-derived quinone-imine reacted with N-acetylcysteine. The product profile observed upon Frémy's salt oxidation of 2-hydroxy-NVP in the presence of ethyl valinate was replicated with myeloperoxidase-mediated oxidation. Additionally, tyrosinase-mediated oxidations selectively yielded 2,3-NVP-quinone-derived products, while quinone-imine-derived products were obtained upon lactoperoxidase catalysis. These observations suggest that the metabolic conversion of phenolic NVP metabolites into quinoid electrophiles is biologically plausible. Moreover, the lack of reaction with sulfhydryl groups might hamper the in vivo detoxification of NVP-derived quinone and quinone-imine metabolites via glutathione conjugation. As a result, these metabolites could be available for reaction with nitrogen-based bionucleophiles (e.g., lysine residues of proteins) ultimately eliciting toxic events.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Centro de Estudos de Doenças Crónicas (CEDOC)RUNHarjivan, Shrika G.Pinheiro, Pedro F.Martins, Inês L.Godinho, Ana L.Wanke, RiccardoSantos, Pedro P.Pereira, Sofia A.Beland, Frederick A.Marques, M. MatildeAntunes, Alexandra M M2023-05-11T22:07:53Z20152015-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article13application/pdfhttp://hdl.handle.net/10362/152628eng2045-452XPURE: 3955463https://doi.org/10.1039/c5tx00176einfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:34:56Zoai:run.unl.pt:10362/152628Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:54:59.753787Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapine
Activation pathway to amino acid adducts
title Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapine
spellingShingle Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapine
Harjivan, Shrika G.
Health, Toxicology and Mutagenesis
Toxicology
SDG 3 - Good Health and Well-being
title_short Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapine
title_full Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapine
title_fullStr Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapine
title_full_unstemmed Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapine
title_sort Quinoid derivatives of the nevirapine metabolites 2-hydroxy- and 3-hydroxy-nevirapine
author Harjivan, Shrika G.
author_facet Harjivan, Shrika G.
Pinheiro, Pedro F.
Martins, Inês L.
Godinho, Ana L.
Wanke, Riccardo
Santos, Pedro P.
Pereira, Sofia A.
Beland, Frederick A.
Marques, M. Matilde
Antunes, Alexandra M M
author_role author
author2 Pinheiro, Pedro F.
Martins, Inês L.
Godinho, Ana L.
Wanke, Riccardo
Santos, Pedro P.
Pereira, Sofia A.
Beland, Frederick A.
Marques, M. Matilde
Antunes, Alexandra M M
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Estudos de Doenças Crónicas (CEDOC)
RUN
dc.contributor.author.fl_str_mv Harjivan, Shrika G.
Pinheiro, Pedro F.
Martins, Inês L.
Godinho, Ana L.
Wanke, Riccardo
Santos, Pedro P.
Pereira, Sofia A.
Beland, Frederick A.
Marques, M. Matilde
Antunes, Alexandra M M
dc.subject.por.fl_str_mv Health, Toxicology and Mutagenesis
Toxicology
SDG 3 - Good Health and Well-being
topic Health, Toxicology and Mutagenesis
Toxicology
SDG 3 - Good Health and Well-being
description Funding: This work was supported in part by Fundação para a Ciência e a Tecnologia (FCT), Portugal (PTDC/QUI-QUI/113910/2009, RECI/QEQ-MED/0330/2012, UID/QUI/00100/2013 and IF/ 01091/2013/CP1163/CT0001), and by Interagency Agreement Y1ES1027 between the National Center for Toxicological Research/Food and Drug Administration and the National Institute of Environmental Health Sciences/National Toxicology Program. The opinions expressed in this paper do not necessarily represent those of the U.S. Food and Drug Administration. RW, ALG, ILM and SGH thank FCT for postdoctoral and doctoral fellowships (SFRH/BPD/70953/2010, SFRH/BD/72301/2010, SFRH/BD/75426/2010 and SFRH/BD/ 80690/2011, respectively). AMM also acknowledges Programa Operacional Potencial Humano from FCT and the European Social Fund (IF/01091/2013), and the LRI Innovative Science Award. We thank the Portuguese NMR and MS networks (IST nodes) for providing access to the facilities.
publishDate 2015
dc.date.none.fl_str_mv 2015
2015-01-01T00:00:00Z
2023-05-11T22:07:53Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/152628
url http://hdl.handle.net/10362/152628
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2045-452X
PURE: 3955463
https://doi.org/10.1039/c5tx00176e
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 13
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138137969000448